Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1878 5
1879 1
1883 1
1885 1
1889 1
1890 1
1901 1
1908 2
1909 1
1910 1
1912 2
1913 1
1915 2
1918 1
1920 1
1921 2
1923 1
1927 3
1937 1
1939 1
1946 2
1947 4
1948 2
1949 3
1950 4
1951 4
1952 6
1953 6
1954 6
1955 3
1956 3
1958 5
1959 2
1960 6
1961 5
1962 11
1963 18
1964 17
1965 9
1966 14
1967 22
1968 24
1969 24
1970 21
1971 26
1972 24
1973 36
1974 14
1975 27
1976 29
1977 16
1978 29
1979 28
1980 12
1981 19
1982 14
1983 10
1984 16
1985 31
1986 22
1987 20
1988 18
1989 22
1990 14
1991 19
1992 31
1993 25
1994 22
1995 28
1996 32
1997 26
1998 36
1999 44
2000 46
2001 50
2002 41
2003 28
2004 40
2005 42
2006 37
2007 34
2008 40
2009 24
2010 33
2011 36
2012 50
2013 33
2014 30
2015 37
2016 32
2017 30
2018 33
2019 38
2020 33
2021 33
2022 37
2023 40
2024 10

Text availability

Article attribute

Article type

Publication date

Search Results

1,729 results

Results by year

Filters applied: . Clear all
Page 1
A Clinical Update on Gestational Diabetes Mellitus.
Sweeting A, Wong J, Murphy HR, Ross GP. Sweeting A, et al. Among authors: ross gp. Endocr Rev. 2022 Sep 26;43(5):763-793. doi: 10.1210/endrev/bnac003. Endocr Rev. 2022. PMID: 35041752 Free PMC article.
Pertuzumab plus trastuzumab in combination with standard neoadjuvant anthracycline-containing and anthracycline-free chemotherapy regimens in patients with HER2-positive early breast cancer: a randomized phase II cardiac safety study (TRYPHAENA).
Schneeweiss A, Chia S, Hickish T, Harvey V, Eniu A, Hegg R, Tausch C, Seo JH, Tsai YF, Ratnayake J, McNally V, Ross G, Cortés J. Schneeweiss A, et al. Among authors: ross g. Ann Oncol. 2013 Sep;24(9):2278-84. doi: 10.1093/annonc/mdt182. Epub 2013 May 22. Ann Oncol. 2013. PMID: 23704196 Free article. Clinical Trial.
Pertuzumab, trastuzumab, and docetaxel in HER2-positive metastatic breast cancer.
Swain SM, Baselga J, Kim SB, Ro J, Semiglazov V, Campone M, Ciruelos E, Ferrero JM, Schneeweiss A, Heeson S, Clark E, Ross G, Benyunes MC, Cortés J; CLEOPATRA Study Group. Swain SM, et al. Among authors: ross g. N Engl J Med. 2015 Feb 19;372(8):724-34. doi: 10.1056/NEJMoa1413513. N Engl J Med. 2015. PMID: 25693012 Free PMC article. Clinical Trial.
Pertuzumab plus trastuzumab plus docetaxel for metastatic breast cancer.
Baselga J, Cortés J, Kim SB, Im SA, Hegg R, Im YH, Roman L, Pedrini JL, Pienkowski T, Knott A, Clark E, Benyunes MC, Ross G, Swain SM; CLEOPATRA Study Group. Baselga J, et al. Among authors: ross g. N Engl J Med. 2012 Jan 12;366(2):109-19. doi: 10.1056/NEJMoa1113216. Epub 2011 Dec 7. N Engl J Med. 2012. PMID: 22149875 Free PMC article. Clinical Trial.
Efficacy and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced, inflammatory, or early HER2-positive breast cancer (NeoSphere): a randomised multicentre, open-label, phase 2 trial.
Gianni L, Pienkowski T, Im YH, Roman L, Tseng LM, Liu MC, Lluch A, Staroslawska E, de la Haba-Rodriguez J, Im SA, Pedrini JL, Poirier B, Morandi P, Semiglazov V, Srimuninnimit V, Bianchi G, Szado T, Ratnayake J, Ross G, Valagussa P. Gianni L, et al. Among authors: ross g. Lancet Oncol. 2012 Jan;13(1):25-32. doi: 10.1016/S1470-2045(11)70336-9. Epub 2011 Dec 6. Lancet Oncol. 2012. PMID: 22153890 Clinical Trial.
Rotenone, paraquat, and Parkinson's disease.
Tanner CM, Kamel F, Ross GW, Hoppin JA, Goldman SM, Korell M, Marras C, Bhudhikanok GS, Kasten M, Chade AR, Comyns K, Richards MB, Meng C, Priestley B, Fernandez HH, Cambi F, Umbach DM, Blair A, Sandler DP, Langston JW. Tanner CM, et al. Among authors: ross gw. Environ Health Perspect. 2011 Jun;119(6):866-72. doi: 10.1289/ehp.1002839. Epub 2011 Jan 26. Environ Health Perspect. 2011. PMID: 21269927 Free PMC article.
5-year analysis of neoadjuvant pertuzumab and trastuzumab in patients with locally advanced, inflammatory, or early-stage HER2-positive breast cancer (NeoSphere): a multicentre, open-label, phase 2 randomised trial.
Gianni L, Pienkowski T, Im YH, Tseng LM, Liu MC, Lluch A, Starosławska E, de la Haba-Rodriguez J, Im SA, Pedrini JL, Poirier B, Morandi P, Semiglazov V, Srimuninnimit V, Bianchi GV, Magazzù D, McNally V, Douthwaite H, Ross G, Valagussa P. Gianni L, et al. Among authors: ross g. Lancet Oncol. 2016 Jun;17(6):791-800. doi: 10.1016/S1470-2045(16)00163-7. Epub 2016 May 11. Lancet Oncol. 2016. PMID: 27179402 Clinical Trial.
Missed Directives.
Ross GS. Ross GS. Ann Intern Med. 2023 Apr;176(4):580-581. doi: 10.7326/M22-3199. Ann Intern Med. 2023. PMID: 37068298 No abstract available.
Porphyria.
Sood S, Mingos N, Ross G. Sood S, et al. Among authors: ross g. N Engl J Med. 2017 Nov 23;377(21):2100. doi: 10.1056/NEJMc1712682. N Engl J Med. 2017. PMID: 29182251 No abstract available.
1,729 results